diabetestalk.net

Ascensia Diabetes Care India

Home | Contour Plus One | Ascensia Diabetes Care

Home | Contour Plus One | Ascensia Diabetes Care

Set remindersto test and add your doctors appointments to your diary. Getting accurate Blood Glucose (BG) results Simple to usethe CONTOURPLUS ONE meter has been shown to deliver remarkably accurate blood glucose results.* The smallest error range met by 95% or more of results was 8.5 mg/dL or 8.5% (vs YSI reference) for subject fingertip tests. *ISO 15197:2013 accuracy requirements (Section 6.3 & Section 8) for in vitro glucose monitoring systems that measure glucose concentrations in capillary blood samples are that at least 95% of results shall fall within 15 mg/dL or 15% of the reference result of the mean YSI reference for samples with glucose concentrations <100 mg/dL and 100 mg/dL, respectively. WithSecond-Chance samplingyou can reapply blood to the strip if the first sample is insufficient. Helps to avoid lancing a second time and wasting strips. ThesmartLIGHTfeature provides you with an instant indicator of your blood glucose results so you know whether they are within, above, or below your target range. Green= within target Amber= above target Red= below target Understanding Blood Glucose (BG) patterns and trends Seamlessly capturedBG readings are used to createpersonalised patterns and trendsto help you see how daily activities impact your results. Understanding the impact of food and activity on Blood Glucose (BG) levels Record eventssuch as diet, activities and medication, alsoadd photos, notes, or voice memos to help put your results in context. Being alerted of critical high and critical low Blood Glucose (BG) levels Alerts are automatically triggeredwhen your blood glucose results are critically high or critically low. The critical high and critical low values can be changed in the app. Talk to your HCP before changing these values. More informed conver Continue reading >>

Ascensia Diabetes Care India Private Limited

Ascensia Diabetes Care India Private Limited

Ascensia Diabetes Care India Private Limited Ascensia Diabetes Care India Private Limited B wing 602, Ashok Enclave,,Chincholi - Link Road Junction,Malad (W),Mumbai,Maharashtra,INDIA,400064 Looking to export your products from India? With end to end global trade solutions from Connect2India, we enable Indian SMEs to start and grow their business globally Ascensia Diabetes Care India Private Limited is a private company. Its address is Its registered address is B wing 602, Ashok Enclave,,Chincholi - Link Road Junction, Mumbai, Maharashtra, 400064. situated in Mumbai.. It was established in 05/11/2015. So, it has 2 Years 10 Months 4 Days year of experience. We are amongst the reputed indian organizations, highly engaged in offering many products / services and optimum quality range.. Indian companies with a wide range of products and services . While operator load/unload the job in the fixture at one station. Business operations will be carried out at the respective stations which result in an increase in productivity drastically. Ascensia Diabetes Care India Private Limited Registration No. is 269883.Ascensia Diabetes Care India Private Limited CIN is FTC269883. Current status of Ascensia Diabetes Care India Private Limited is - Active. Continue reading >>

Ascensia Diabetes Care | Contact Us

Ascensia Diabetes Care | Contact Us

Please provide us with information about your query in the box below If your question is about one of our meters please tell us which of our meters you use We would like to send you information about our products, offers and promotions. If you would like to receive this information please indicate your acceptance by ticking the box below. You can unsubscribe at any time. I am happy to receive information from Ascensia by email Your submission has been successfully received. A customer service agent will review and contact you shortly. This form could not be submitted at this time. Please contact our customer support team at [insert preferred contact method]. Ascensia Diabetes Care offers comprehensive Customer Support for both Consumers and Health Care Professionals. Email Support - Contact Us at [email protected] Customer Service - 1-800-123-0123 available from9.30 am to 6.00 pm IST (Monday to Saturday) You can play an important public health role by providing feedback on any adverse reactions or other product issues you've encountered with Ascensia Diabetes care products. To report an adverse event or to voluntarily report an error or issue with a Ascensia Diabetes product please call our customer service representatives at 1800-123-0123. 2017 Ascensia Diabetes Care Holdings AG. All rights reserved. Ascensia, the Ascensia Diabetes Care logo, Contour, Microlet, Glucofacts, the No Coding logo, and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google Inc. The Bluetoothword mark and logos are registered trademarks owned by Bl Continue reading >>

Ascensia Diabetes Challenge

Ascensia Diabetes Challenge

Do you have a digital solution for the global epidemic oftype 2 diabetes? Ascensia Diabetes Care has partnered with yet2 to launch the Ascensia Diabetes Challenge A GLOBAL INNOVATION COMPETITION. Weare seeking submissions for innovative digital solutions that can genuinely change behavior and improve the lives of people with type 2 diabetes. We want to support companies who are developing the next big leap forward in digital solutions for self-management of type 2 diabetes. The six entries that will progress to the finalist stage of the Ascensia Diabetes Challenge have been announced. The six finalists were selected from 116 submissions and chosen by a panel of external experts and members of the Ascensia Medical, R&D and Commercial teams. The selected entrants will receive 10,000 Euros for reaching this stage and are due to present their solutions at the finalist event in April to determine the winner. For more information, visit: www.ascensia.com/press/ . The Ascensia Diabetes Challenge has now closed for entries. Thank you to all the startups and entrepreneurs that submitted. Our judges will be reviewing the entries and selecting up to six finalists who will each receive a cash prize and be invited to our finalist event. Please check back later in March to hear who has reached the finalist stage. Submissions deadline now February 23, 2018 Entrants now have until Friday February 23, 2018 to submit their innovative, patient-centric, digital solutions to support diabetes management. Submit your entry for the Ascensia Diabetes Challenge below. Two new judges that have been announced for the Ascensia Diabetes Challenge. Healthcare innovation experts Dr Neal Kaufman, USA, and Dr Sidney Yee, Singapore, have both joined the judging panel for the competition. This comes as t Continue reading >>

Industry Leaders Ascensia Diabetes Care And Glooko Announce Diabetes Technology Partnership To Deliver Integrated Diabetes Data Solutions

Industry Leaders Ascensia Diabetes Care And Glooko Announce Diabetes Technology Partnership To Deliver Integrated Diabetes Data Solutions

Industry Leaders Ascensia Diabetes Care and Glooko Announce Diabetes Technology Partnership to Deliver Integrated Diabetes Data Solutions BASEL, Switzerland and MOUNTAIN VIEW, California, January 31, 2017 /PRNewswire/ -- Ascensia Diabetes Care and Glooko, Inc today announced a global technology partnership designed to bring together their state-of-the-art diabetes management solutions, and improve diabetes data management and analytics. This collaboration includes integration of Glooko's Diabetes Data Management Platform and Ascensia's CONTOURNEXT ONE and CONTOURPLUS ONE blood glucose monitoring systems. The integration of these solutions will allow people with diabetes and health care professionals to access and analyze highly accurate blood glucose data at home, on the move and during office visits through the digital platform of their choice. "Glooko's Diabetes Data Management Platform has become widely used for both personal and clinical diabetes data analytics and decision support," said Michael Kloss, CEO of Ascensia Diabetes Care. He continued, "Glooko's broad distribution into health systems will enable us to easily and seamlessly deliver highly accurate data from our CONTOUR NEXTONE and CONTOURPLUS ONE blood glucose monitoring systems to clinicians right in their workflow. By linking our systems to Glooko's Diabetes Data Management Platform, we want to enable better understanding and analysis of diabetes data, and ultimately help to improve the lives of people with diabetes." The integration of these solutions will allow blood glucose data to be accessed by Glooko's Mobile App and Clinic Data Upload products directly from the CONTOURNEXT ONE and CONTOURPLUS ONE meters via Bluetooth connectivity and through an automatic feed via the CONTOUR CLOUD. People with d Continue reading >>

Ascensia Diabetes Care India Private Limited - Company Reports And Balance Sheets - Tofler

Ascensia Diabetes Care India Private Limited - Company Reports And Balance Sheets - Tofler

ASCENSIA DIABETES CARE INDIA PRIVATE LIMITED Ascensia Diabetes Care India Private Limited is an unlisted private company incorporated on 05 November, 2015. The registered office of the company is at 1st Floor, Bella Vista, Oswal Park,Pokhran Road No 2, Majiwada Junction, Thane (W), Thane West, Thane, Maharashtra. The total paid-up capital is INR 15.00 cr. The company has no reported secured loans. The last reported AGM (Annual General Meeting) of the company, per our records, was held on 30 September, 2016. Also, as per our records, its last balance sheet was prepared for the period ending on 31 March, 2016. The company has 3 directors/key management personnel. Login for email address. This is to prevent spam. Pokhran Road No 2, Majiwada Junction, Thane (W) No previous names were found for this company. No previous CINs were found for this company. Balance Sheet, Profit and Loss# and shareholder return for 31 March, 2016 along with latest MoA and AoA. Delivery time: 8 working hours (Mon-Fri). ** Company has reported to have approved financials for 31 March, 2016. However, in case, they are not yet filed with MCA, then last filed financials shall be provided instead. ASCENSIA DIABETES CARE INDIA PRIVATE LIMITED ASCENSIA DIABETES CARE INDIA PRIVATE LIMITED Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. # The above information is purely a summary of the contents and status of documents examined on an inspection of the Company's documents available on the official website of the Min Continue reading >>

Talent Acquisition Partner (contract) - Ascensia Diabetes Care (thane)

Talent Acquisition Partner (contract) - Ascensia Diabetes Care (thane)

Ascensia Diabetes Care India private Limited 6,00,000 - 8,00,000 P.A. Openings: 1 Posted 2 days ago Job Applicants: Less than 10 Job Views: 102 Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes. Our mission is to empower people living with diabetes through innovative solutions that simplify and improve their lives. We use our innovation and specialist expertise in diabetes to develop high quality solutions and tools that make a positive, daily difference for people with diabetes Position: Recruiter (Talent Acquisition Partner) on Contract We are looking for an experienced recruiter to join our global Talent Acquisition team. You will manage all aspects of the recruitment process in India with a focus on attracting people who have the key competencies needed to support our growth plans and who want to work at a company where they can make an impact. If you love the challenge of sourcing and hiring great candidates, if you have great organizational and relationship skills along with a passion for recruiting we want to talk to you. Major tasks and responsibilities of position: Manages all aspects of the recruiting process for non-exempt levels, works in partnership with HRBP to support recruitment for manager level positions. Partners closely with hiring manager from intake meeting, through candidate sourcing, identification, initial phone screens and interview scheduling, final selection, offer proposal and negotiation, Execute various sourcing strategies including internet job boards, networking, social media, resume mining and employee referrals to identify and build a talent pipeline You will help to ensure hiring managers follow our global recruitment processes Recommends candidate shortlist to hirin Continue reading >>

Roche Diabetes Care Looks To Double Its Retail Presence In India

Roche Diabetes Care Looks To Double Its Retail Presence In India

Roche Diabetes Care looks to double its retail presence in India The company is looking to cover 60% of the market in next 5 years Roche Diabetes Care India, a part of Roche Diagnostics India, which hived off into a separate entity last November, is planning to double its retail reach. The company, which sells equipment for self-monitoring of blood glucose (SMBG) under the brand Accu-Check, will double outlets to 1.2 lakh pharmacy outlets in the next five years. The company is looking to tie up with state and central government to expand reach. Sidhartha Roy, general manager at Roche Diabetes Care India said, " We will be embarking on a model where we intend to double the reach in the next ... TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST Rs Key stories on business-standard.com are available to premium subscribers only. Pay Using International Credit Card (Issued by bank outside India) Note: Subscription will be auto renewed, you may cancel any time in the future without any questions asked. Unlimited access to all the content on any device through browser or app. Exclusive content, features, opinions and comment hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. Requires you to share personal information like date of birth, income, location amongst other fields. This information alongwith your contact information will be shared with the partners associated with this program, who contribute towards subsidizing the offer. By subscribing to this product you acknowledge and accept that our Partners may choose to contact you with offers Continue reading >>

Ascensia Diabetes Care Jobs

Ascensia Diabetes Care Jobs

Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes. Our mission is to empower people living with diabetes through innovative solutions that simplify and improve their lives. We use our innovation and specialist expertise in diabetes to develop high quality solutions and tools that make more... a positive, daily difference for people with diabetes. Home to the world renowned CONTOUR portfolio of blood glucose monitoring systems, our products combine advanced technology with user-friendly functionality that help people with diabetes to manage their condition. We are committed to continued research, innovation and development of new products and solutions. As a trusted partner in the diabetes community, we collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy, precision and reliability, and that we conduct our business compliantly and with integrity. At Ascensia, our company values are based on our mission to empower people living with diabetes through innovative solutions that simplify and improve their lives. They are the foundations and beliefs that are common to all employees at Ascensia Diabetes Care and they provide guidance on how we conduct business and how we work together. We are customer focused. We listen to people living with diabetes, seek to understand their challenges and provide meaningful solutions. We demonstrate excellence. We strive for excellence in all aspects of our work and deliver high quality products and solutions that are accurate, precise and reliable. We are trusted. We are a trusted partner in the diabetes community, are a leader in providing reliable products, and ensure integrity in our daily work Continue reading >>

Ascensia Diabetes Care Renews International Alliance With Medtronic - The Hindu Businessline

Ascensia Diabetes Care Renews International Alliance With Medtronic - The Hindu Businessline

Ascensia Diabetes Care renews international alliance with Medtronic Today Ascensia Diabetes Care announced that it has renewed its global alliance with Medtronic plc to develop and market innovative diabetes management solutions for patients worldwide. As part of the agreement, Ascensia Diabetes Care will continue to exclusively co-develop and supply CONTOUR NEXT LINK and CONTOUR PLUS LINK blood glucose meters that are wirelessly compatible to communicate with Medtronics integrated insulin pump and continuous glucose monitoring (CGM) systems. The renewal announced today lasts for five years, and follows more than eight years of successful worldwide collaboration. Michael Kloss, CEO of Ascensia Diabetes Care, explained, To date we have launched three meter generations with Medtronic MiniMed insulin pump systems across the world and have seen tremendous success with this alliance. Medtronic is leading the path towards the artificial pancreas through their research and development. It is testament to the high quality and remarkable accuracy of our blood glucose monitoring systems that Medtronic has chosen them as part of their MiniMed insulin pump systems. We are delighted to collaborate with Medtronic on future insulin pump systems to simplify and improve the lives of people with diabetes. Alejandro Galindo, president of the Intensive Insulin Management Business at Medtronic, said, Medtronic aims to transform diabetes care around the world through continuous product innovations so that people living with diabetes can enjoy greater freedom and better health. We are excited to continue our strategic alliance with Ascensia as we strive to achieve this goal. Michael Kloss added, At Ascensia Diabetes Care, we believe that the sharing of knowledge and expertise is vital to hel Continue reading >>

Ascensia Diabetes Care Holdings

Ascensia Diabetes Care Holdings

Implementing a successful global structure In early 2016, Ascensia Diabetes Care Holdings AG successfully established as a new company. This followed the completion of the acquisition by Panasonic Healthcare Holdings of the Diabetes Care business from Bayer. The tax side of the transaction was supported by a comprehensive Deloitte team. Deloitte assisted Panasonic Healthcare and KKR funds in the acquisition of the worldwide Diabetes Care business from Bayer. Deloittes support was not limited to the tax structuring services but was also actively involved in considerations around financing and a the selection of new global headquarters, named Ascensia Diabetes Care Holdings AG, located in Switzerland. The complexity of the transaction required continuous dedication from Deloitte teams across the globe and a strong collaboration with our client. Deloitte assisted our team on this transaction from day one and was always ready to adapt to new situations and circumstances. Even post-closing, we can still rely on the tax expertise of Deloitte for assistance during the implementation phase. Jan Vannerum, CFO/CAO, Ascensia Diabetes Care Holdings AG Continue reading >>

Panasonic Healthcare Holdings Completes Acquisition Of Leading Diabetes Care Business From Bayer Ag

Panasonic Healthcare Holdings Completes Acquisition Of Leading Diabetes Care Business From Bayer Ag

Panasonic Healthcare Holdings Completes Acquisition of Leading Diabetes Care Business from Bayer AG January 05, 2016 02:30 AM Eastern Standard Time TOKYO--( BUSINESS WIRE )--Panasonic Healthcare Holdings, Co., Ltd. (Panasonic Healthcare) and Bayer Aktiengesellschaft (Bayer AG) today announced the completion of Panasonic Healthcares acquisition of Bayer AGs Diabetes Care business. Panasonic Healthcare is backed by funds sponsored by leading global investment firm KKR and the Panasonic Corporation. The total consideration for the transaction is around EUR 1 billion (approximately 132 billion at the exchange rate of EUR1=132). The acquired Diabetes Care business will operate as a stand-alone company named Ascensia Diabetes Care that will provide high-quality solutions and precision tools to serve the needs of people with diabetes. Together Ascensia Diabetes Care and Panasonic Healthcare will develop, manufacture, market and sell blood glucose monitoring meters and strips for people with diabetes in more than 125 countries. Hidehito Kotani, President of Panasonic Healthcare said, Our goal is to ensure high-quality technologies and diabetes care solutions are available to all patients who need them. Bringing together Panasonic Healthcare and Ascensia Diabetes Care will significantly help to achieve this goal. Together with KKR, the companies will be able to serve more patients in more places across the globe with world-class products. We greatly look forward to expanding this business and innovating new solutions at this integral point in the diabetes care industry. Michael Kloss, Chief Executive Officer of Ascensia Diabetes Care, added, We are excited to launch as Ascensia Diabetes Care and continue to be a trustworthy provider of reliable, high-performance solutions that Continue reading >>

Ascensia Diabetes Care: Developing Innovative Solutions For Diabetes Management

Ascensia Diabetes Care: Developing Innovative Solutions For Diabetes Management

Ascensia Diabetes Care: Developing innovative solutions for Diabetes Management Innovation is in our DNA, and is the key to developing new solutions for our customers, mentions Michael Kloss, CEO of Ascensia Diabetes Care. As a company that aims to lead in diabetes care, we want to understand the needs of people living with diabetes and provide solutions that help them address those needs. Ascensia Diabetes Care was established in 2016 through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings. The company has a longstanding history in the diabetes community and a proud legacy of innovations and firsts in diabetes management. Ascensia is now continuing to use these many years of experience and specialist subject expertise in diabetes to develop high-quality solutions for patients. The company markets blood glucose monitoring devices and combines advanced technology with user-friendly functionality that can help patients with diabetes to better monitor and manage their condition. Ascensia is known for their highly accurate meters and the CONTOUR PLUS, which is widely available across the region, has proven accuracy, especially at low blood glucose ranges. It is built on the standards of ISO 15197:2013, using remarkable accuracy technology to deliver results that patients can trust. The CONTOUR PLUS also includes the Second Chance sampling feature that allows a patient to add another drop of blood within 30 seconds if the first one wasnt enough, helping to prevent wastage of test strips. This feature helps patients with an issue they face in their diabetes management patient. It demonstrates patient-centered innovation and is exactly how we want to continue to develop our products added Kloss. In Asia, the firms latest innovation is the CONTOUR PLUS ONE blo Continue reading >>

Ascensia | Phc Corporation

Ascensia | Phc Corporation

Our goal is to provide products and solutions that make a positive, daily difference for people with diabetes and enable them to live richer lives. At Ascensia Diabetes Care we want to serve the needs of patients through our innovation and specialist expertise in diabetes. We create high quality solutions and precision tools that help patients manage their diabetes and take charge of their lives. We are proud of our heritage as a leading provider of solutions for diabetes care. We will continue to build on the legacy of our longstanding commitment to diabetes. Established through the acquisition of Bayer Diabetes Care by PHC Holdings Corporation Ascensia Diabetes Care is a global company dedicated to improving the lives of people with diabetes and helping empower them to take charge of their health. Ascensia Diabetes Care is the recognized world leader in delivering convenient, easy-to-use blood glucose monitoring systems and testing supplies. We collaborate closely with healthcare professionals and other partners to ensure our products meet the high standards of accuracy to help people with diabetes manage their condition, regardless of type of diabetes, stage of disease or frequency of testing required. For more than 70 years, continuous research has allowed our diabetes care team to lead the way in blood glucose monitoring systems. These have been developed specifically to meet the needs of patients, and, along the way, we have introduced many high quality products. Our portfolio of products combines advanced technology with user-friendly functionality that helps people with diabetes to help manage their condition and improve their quality of life. We offers highly accurate and easy-to-use blood glucose monitoring systems. The advanced range of features helps people Continue reading >>

Ascensia Diabetes Care And Health2sync Announce Collaboration To Bring Digital Diabetes Management Solution To Patients In Asia

Ascensia Diabetes Care And Health2sync Announce Collaboration To Bring Digital Diabetes Management Solution To Patients In Asia

Ascensia Diabetes Care and Health2Sync Announce Collaboration to Bring Digital Diabetes Management Solution to Patients in Asia BASEL, Switzerland and TAIPEI, Taiwan, November 28, 2017 /PRNewswire/ -- Ascensia Diabetes Care and Health2Sync today announced a collaboration that aims to improve diabetes care by bringing an integrated digital management solution to patients in Asia. As part of this collaboration, the companies will create a combined offering for people with diabetes that comprises of the CONTOURPLUS or CONTOURTS blood glucose monitoring systems from Ascensia, the Health2Sync app and a loyalty program for users, known as the Ascensia Customer Care Program. Once the combined offering is launched, when people with diabetes purchase the CONTOURPLUS or CONTOURTS systems, they will be able to join the Ascensia Customer Care Program after registering for an account in the Health2Sync mobile app. Membership benefits include discount coupons for test strips, promotions and educational materials about diabetes. By using the Health2Sync app, people with diabetes will be able to log their blood glucose readings, track their blood glucose values, and make decisions related to diabetes management based on the analyses provided. A Bluetooth wireless technology enabled dongle from Health2Sync is also available. This dongle connects to the meter and allows data to be directly downloaded from the meter to the app. "This collaboration with Health2Sync will enable us to bring an effective digital management solution to people with diabetes in Asia" explained Michael Kloss, CEO, Ascensia Diabetes Care. "By bringing together the accuracy and user friendly features of our meters with the innovative software capabilities in the Health2Sync app, we are able to provide significant Continue reading >>

More in diabetes